Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (Q82294729)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 October 2008
edit
Language Label Description Also known as
English
Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)
scientific article published on 14 October 2008

    Statements

    title
    Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    18854571
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18854571%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    15 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q82294729&oldid=2037997424"